If you have already read the complete guide to GLP-1 medications, you know how that mechanism works the appetite signaling, the slowed gastric emptying, the glucose-dependent insulin release
Initially studied for diabetes management and obesity, GLP-1 receptor agonists (GLP-1RAs) have garnered interest for their potential in addressing substance use disorders
Examples of laminopathies include EmeryDreifuss muscular dystrophy (EDMD), limb-girdle muscular dystrophy type 1B (LGMD1B) has been reclassified as EDMD2, congenital muscular dystrophy (CMD), dilated cardiomyopathy type 1A, familial partial lipodystrophy type 2, and early aging syndromes such as HutchinsonGilford progeria syndrome 5
The stomach essentially stops functioning normally
Outcome: CGM-guided dosing achieved ~90 % time-in-range vs ~60 % with point-of-care monitoring